Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1993;2(3):217–223. doi: 10.1155/S0962935193000298

The temporal relationship between the neural and vascular actions of kallidin within the nose

K Rajakulasingam 1,✉, L C K Lau 1, R Polosa 1, M K Church 1, S T Holgate 1, P H Howarth 1
PMCID: PMC2365406  PMID: 18475525

Abstract

The time course of effect of the B2-receptor agonist kallidin (K) on induced changes of nasal airflow, rhinorrhoea, nasal pain, sneezing and nasal microvascular leakage has been examined and compared with its B2 metabolite agonist bradykinin (B) and the B1-agonist [des-arg9]-bradykinin (D). When administered as a single dose K and B induced an immediate sensation of pain, rhinorrhoea, elevations in lavage albumin and protein levels and a sustained increase in nasal airways resistance (NAR) for 5–40 min post-challenge. [des-arg9]-Bradykinin and vehicle placebo (V) were without effect on any of these indices. These studies identify the action of K and B within the nose and differentiate the neural and vascular effects of these kinins in addition to suggesting the potential that nasal blockage and nasal microvascular leakage represent alterations in differing vascular compartments. These findings have implications for the understanding and therapeutic manipulation of rhinitis.

Full Text

The Full Text of this article is available as a PDF (621.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baraniuk J. N., Lundgren J. D., Mizoguchi H., Peden D., Gawin A., Merida M., Shelhamer J. H., Kaliner M. A. Bradykinin and respiratory mucous membranes. Analysis of bradykinin binding site distribution and secretory responses in vitro and in vivo. Am Rev Respir Dis. 1990 Mar;141(3):706–714. doi: 10.1164/ajrccm/141.3.706. [DOI] [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  3. Cauna N., Hinderer K. H. Fine structure of blood vessels of the human nasal respiratory mucosa. Ann Otol Rhinol Laryngol. 1969 Aug;78(4):865–879. doi: 10.1177/000348946907800418. [DOI] [PubMed] [Google Scholar]
  4. Churchill L., Pongracic J. A., Reynolds C. J., Naclerio R. M., Proud D. Pharmacology of nasal provocation with bradykinin: studies of tachyphylaxis, cyclooxygenase inhibition, alpha-adrenergic stimulation, and receptor subtype. Int Arch Allergy Appl Immunol. 1991;95(4):322–331. doi: 10.1159/000235469. [DOI] [PubMed] [Google Scholar]
  5. Conklin B. R., Burch R. M., Steranka L. R., Axelrod J. Distinct bradykinin receptors mediate stimulation of prostaglandin synthesis by endothelial cells and fibroblasts. J Pharmacol Exp Ther. 1988 Feb;244(2):646–649. [PubMed] [Google Scholar]
  6. Geppetti P., Fusco B. M., Alessandri M., Tramontana M., Maggi C. A., Drapeau G., Fanciullacci M., Regoli D. Kallidin applied to the human nasal mucosa produces algesic response not blocked by capsaicin desensitization. Regul Pept. 1991 May 17;33(3):321–329. doi: 10.1016/0167-0115(91)90234-8. [DOI] [PubMed] [Google Scholar]
  7. Kaufman M. P., Coleridge H. M., Coleridge J. C., Baker D. G. Bradykinin stimulates afferent vagal C-fibers in intrapulmonary airways of dogs. J Appl Physiol Respir Environ Exerc Physiol. 1980 Mar;48(3):511–517. doi: 10.1152/jappl.1980.48.3.511. [DOI] [PubMed] [Google Scholar]
  8. Leikauf G. D., Ueki I. F., Nadel J. A., Widdicombe J. H. Bradykinin stimulates Cl secretion and prostaglandin E2 release by canine tracheal epithelium. Am J Physiol. 1985 Jan;248(1 Pt 2):F48–F55. doi: 10.1152/ajprenal.1985.248.1.F48. [DOI] [PubMed] [Google Scholar]
  9. Lundberg J. M., Saria A. Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants. Nature. 1983 Mar 17;302(5905):251–253. doi: 10.1038/302251a0. [DOI] [PubMed] [Google Scholar]
  10. MCCARTHY D. A., POTTER D. E., NICOLAIDES E. D. AN IN VIVO ESTIMATION OF THE POTENCIES AND HALF-LIVES OF SYNTHETIC BRADYKININ AND KALLIDIN. J Pharmacol Exp Ther. 1965 Apr;148:117–122. [PubMed] [Google Scholar]
  11. Mygind N., Secher C., Kirkegaard J. Role of histamine and antihistamines in the nose. Eur J Respir Dis Suppl. 1983;128(Pt 1):16–20. [PubMed] [Google Scholar]
  12. Naclerio R. M., Proud D., Togias A. G., Adkinson N. F., Jr, Meyers D. A., Kagey-Sobotka A., Plaut M., Norman P. S., Lichtenstein L. M. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985 Jul 11;313(2):65–70. doi: 10.1056/NEJM198507113130201. [DOI] [PubMed] [Google Scholar]
  13. Polosa R., Holgate S. T. Comparative airway response to inhaled bradykinin, kallidin, and [des-Arg9]bradykinin in normal and asthmatic subjects. Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1367–1371. doi: 10.1164/ajrccm/142.6_Pt_1.1367. [DOI] [PubMed] [Google Scholar]
  14. Proud D., Baumgarten C. R., Naclerio R. M., Ward P. E. Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis. J Immunol. 1987 Jan 15;138(2):428–434. [PubMed] [Google Scholar]
  15. Proud D., Kaplan A. P. Kinin formation: mechanisms and role in inflammatory disorders. Annu Rev Immunol. 1988;6:49–83. doi: 10.1146/annurev.iy.06.040188.000405. [DOI] [PubMed] [Google Scholar]
  16. Proud D., Reynolds C. J., Lacapra S., Kagey-Sobotka A., Lichtenstein L. M., Naclerio R. M. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis. 1988 Mar;137(3):613–616. doi: 10.1164/ajrccm/137.3.613. [DOI] [PubMed] [Google Scholar]
  17. Proud D., Togias A., Naclerio R. M., Crush S. A., Norman P. S., Lichtenstein L. M. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest. 1983 Nov;72(5):1678–1685. doi: 10.1172/JCI111127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rajakulasingam K., Polosa R., Holgate S. T., Howarth P. H. Comparative nasal effects of bradykinin, kallidin and [Des-Arg9]-bradykinin in atopic rhinitic and normal volunteers. J Physiol. 1991 Jun;437:577–587. doi: 10.1113/jphysiol.1991.sp018612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rangachari P. K., McWade D., Donoff B. Luminal receptors for bradykinin on the canine tracheal epithelium: functional subtyping. Regul Pept. 1988 Jun;21(3-4):237–244. doi: 10.1016/0167-0115(88)90006-7. [DOI] [PubMed] [Google Scholar]
  20. Regoli D., Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980 Mar;32(1):1–46. [PubMed] [Google Scholar]
  21. Reis M. L., Okino L., Rocha e Silva M. Comparative pharmacological actions of bradykinin and related kinins of larger molecular weights. Biochem Pharmacol. 1971 Nov;20(11):2935–2946. doi: 10.1016/0006-2952(71)90096-7. [DOI] [PubMed] [Google Scholar]
  22. Stjärne P., Lundblad L., Lundberg J. M., Anggård A. Capsaicin and nicotine-sensitive afferent neurones and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis. Br J Pharmacol. 1989 Mar;96(3):693–701. doi: 10.1111/j.1476-5381.1989.tb11870.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Svensson C., Andersson M., Persson C. G., Venge P., Alkner U., Pipkorn U. Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol. 1990 May;85(5):828–833. doi: 10.1016/0091-6749(90)90064-b. [DOI] [PubMed] [Google Scholar]
  24. Weeke B. Rocket immunoelectrophoresis. Scand J Immunol Suppl. 1973;1:37–46. doi: 10.1111/j.1365-3083.1973.tb03777.x. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES